Company intelligence / Profile preview

Atlas Research

Ownership: Private
Development stage: Other

Overview

Atlas Clinical Research operates a therapeutically-focused network of clinical trial sites that have collectively performed over 1,000 clinical trials and enrolled more than 40,000 volunteers. The company partners with biopharma sponsors and CROs to accelerate access to new treatments by providing high-quality data and diverse patient populations. Their focus areas include internal medicine, CNS disorders, GI medicine, and infectious disease. They emphasize patient-centered care and operational excellence.

Therapeutic areas: OtherGastroenterologyNeurologyInfectious Diseases
Modalities: Small moleculeBiologicMonoclonal antibodyGene therapyCell therapy
Industry: Contract Research Organization

Partnerships

Partners with over 200 biopharma sponsors and CROs for conducting clinical research studies.

Beyond the preview

Go deeper on Atlas Research.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Atlas Research.

Explore the full profile